PT1093380E - Componente b como agente angiogenico em combinacao com factores de crescimento humano - Google Patents

Componente b como agente angiogenico em combinacao com factores de crescimento humano

Info

Publication number: PT1093380E
Authority: PT; Portugal
Prior art keywords: combination; human growth; component; growth factors; angiogenic agent
Prior art date: 1998-07-09

Application number

PT99934563T

Other languages

English (en)

Inventor

Francesco Borrelli

Marina Ziche

Silvia Donini

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-09

Filing date

1999-07-02

Publication date

2003-01-31

1999-07-02 Application filed by Applied Research Systems filed Critical Applied Research Systems

2003-01-31 Publication of PT1093380E publication Critical patent/PT1093380E/pt

Links

239000003102 growth factor Substances 0.000 title abstract 2
230000002491 angiogenic effect Effects 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
102100024785 Fibroblast growth factor 2 Human genes 0.000 abstract 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 abstract 1
230000033115 angiogenesis Effects 0.000 abstract 1
230000001656 angiogenetic effect Effects 0.000 abstract 1
230000034303 cell budding Effects 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Cell Biology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Developmental Biology & Embryology (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

PT99934563T 1998-07-09 1999-07-02 Componente b como agente angiogenico em combinacao com factores de crescimento humano PT1093380E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98112775		1998-07-09

Publications (1)

Publication Number	Publication Date
PT1093380E true PT1093380E (pt)	2003-01-31

Family

ID=8232248

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99934563T PT1093380E (pt)	1998-07-09	1999-07-02	Componente b como agente angiogenico em combinacao com factores de crescimento humano

Country Status (12)

Country	Link
US (2)	US6855684B2 (pt)
EP (1)	EP1093380B1 (pt)
JP (1)	JP2002520292A (pt)
AT (1)	ATE224200T1 (pt)
AU (1)	AU765600B2 (pt)
CA (1)	CA2336773C (pt)
DE (1)	DE69903037T2 (pt)
DK (1)	DK1093380T3 (pt)
ES (1)	ES2184480T3 (pt)
IL (2)	IL140778A0 (pt)
PT (1)	PT1093380E (pt)
WO (1)	WO2000002579A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000002579A2 (en) *	1998-07-09	2000-01-20	Applied Research Systems Ars Holding N.V.	Component b as angiogenic agent in combination with human growth factors
AU2001291019A1 (en)	2000-09-15	2002-03-26	Genvec, Inc.	Method of modulating neovascularization
AU2004229237B2 (en)	2003-04-16	2009-06-04	Merck Serono Sa	Use of SLURP-1 for treating diseases related to acetylcholine receptors dysfunction
WO2006060803A2 (en) *	2004-12-03	2006-06-08	Polnox Corporation	One pot process for making polymeric antioxidants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1257184B (it) *	1992-12-22	1996-01-10	Applied Research Systems	Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
WO1997039765A1 (en) *	1996-04-24	1997-10-30	Applied Research Systems Ars Holding N.V.	Component b as cicatrizant
WO2000002579A2 (en) *	1998-07-09	2000-01-20	Applied Research Systems Ars Holding N.V.	Component b as angiogenic agent in combination with human growth factors

1999
- 1999-07-02 WO PCT/EP1999/004605 patent/WO2000002579A2/en not_active Ceased
- 1999-07-02 CA CA002336773A patent/CA2336773C/en not_active Expired - Fee Related
- 1999-07-02 DE DE69903037T patent/DE69903037T2/de not_active Expired - Lifetime
- 1999-07-02 ES ES99934563T patent/ES2184480T3/es not_active Expired - Lifetime
- 1999-07-02 PT PT99934563T patent/PT1093380E/pt unknown
- 1999-07-02 DK DK99934563T patent/DK1093380T3/da active
- 1999-07-02 JP JP2000558838A patent/JP2002520292A/ja active Pending
- 1999-07-02 IL IL14077899A patent/IL140778A0/xx active IP Right Grant
- 1999-07-02 EP EP99934563A patent/EP1093380B1/en not_active Expired - Lifetime
- 1999-07-02 AU AU50306/99A patent/AU765600B2/en not_active Ceased
- 1999-07-02 AT AT99934563T patent/ATE224200T1/de active
2001
- 2001-01-08 IL IL140778A patent/IL140778A/en not_active IP Right Cessation
- 2001-01-09 US US09/756,185 patent/US6855684B2/en not_active Expired - Fee Related
2004
- 2004-12-10 US US11/008,175 patent/US7223732B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL140778A (en)	2008-03-20
US7223732B2 (en)	2007-05-29
DE69903037T2 (de)	2003-06-05
AU765600B2 (en)	2003-09-25
DE69903037D1 (de)	2002-10-24
US6855684B2 (en)	2005-02-15
AU5030699A (en)	2000-02-01
EP1093380B1 (en)	2002-09-18
CA2336773A1 (en)	2000-01-20
CA2336773C (en)	2009-12-15
EP1093380A2 (en)	2001-04-25
WO2000002579A3 (en)	2000-02-24
US20010031733A1 (en)	2001-10-18
WO2000002579A2 (en)	2000-01-20
DK1093380T3 (da)	2003-01-27
US20050153892A1 (en)	2005-07-14
JP2002520292A (ja)	2002-07-09
ES2184480T3 (es)	2003-04-01
IL140778A0 (en)	2002-02-10
ATE224200T1 (de)	2002-10-15

Similar Documents

Publication	Publication Date	Title
ES2095017T3 (es)	1997-02-01	Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete.
AR003123A1 (es)	1998-07-08	Una composicion sinergica de por lo menos un compuesto de actividad antimicrobiana y de por lo menos un monoalquileter de glicerol y utilizacionesde los mismos como agentes antimicrobianos en una composicion cosmetica o farmaceutica como asi tambien en la preparacion de composiciones farmaceuticas
TR200003635T2 (tr)	2001-04-20	Peg-IFN-ALFA ve ribavirinin kronik hepatit C tedavisinde kullanılması.
DK1235571T3 (da)	2005-01-17	Anvendelse af melatonin til behandling af androgenetisk eller diffus alopecia af feminin type
BR9913932A (pt)	2001-10-16	Uso de análogos de glp-1 no tratamento de derrame
BR0003897A (pt)	2001-04-03	Aditivo para aumento da resistência à água de formulações cosméticas ou dermatológicas e seus usos
ATE288749T1 (de)	2005-02-15	Verwendung von kannabidiol als entzündunghemmende mittel
SE9701162D0 (sv)	1997-03-27	New use II
BR0115323A (pt)	2004-02-17	Uso de cci-779 como agente antineoplástico
DE69922152D1 (de)	2004-12-30	Stabile ascorbinsäure enthaltende zubereitung zur topischen anwendung
DE69921318D1 (de)	2004-11-25	Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
IT1264530B (it)	1996-10-02	Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
PT1093380E (pt)	2003-01-31	Componente b como agente angiogenico em combinacao com factores de crescimento humano
IS2171B (is)	2006-11-15	Samsetning sem eykur hreyfanleika
ES2178405T3 (es)	2002-12-16	Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
ATE270865T1 (de)	2004-07-15	Kompressionsverband
ATE232398T1 (de)	2003-02-15	Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid
ES2189206T3 (es)	2003-07-01	Beta-alcoxiacrilatos contra la malaria.
BR9301375A (pt)	1993-10-13	Composicao cosmetica
ES2196171T3 (es)	2003-12-16	Agentes antitumorales de tioxantenona liofilizada.
DE69808663D1 (de)	2002-11-14	Neomycin/disaccharid wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie
ES2152664T3 (es)	2001-02-01	Combinacion de cis-4-hidroxi-l-prolina y n-metil-cis-4-hidroxi-l-prolina para aplicacion como agente terapeutico, especialmente para el tratamiento contra el cancer.
ATE453410T1 (de)	2010-01-15	Stabile zubereitungen mit hyperforin
SE8802257D0 (sv)	1988-06-16	Antimikrobiell komposition
PT1313500E (pt)	2005-02-28	Associacoes de dalfopristina/quinupristina com o cefpirome